Appendicitis medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 55: Line 55:
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Metronidazole]]'''''<BR>''OR''<BR>▸ '''''[[Clindamycin]]'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Metronidazole]]'''''<BR>''OR''<BR>▸ '''''[[Clindamycin]]'''''
|-
|}
|}
{| style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 600px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Community-acquired infection in adults}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Mild-to-moderate severity'''''
|-|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Single Agent'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefoxitin]]'''''<BR>''OR''<BR>▸ '''''[[Ertapenem]]'''''<BR>''OR''<BR> ▸ '''''[[moxifloxacin]]'''''<BR>''OR''<BR>▸ '''''[[Tigecycline]]'''''<BR>''OR''<BR>▸ '''''[[Ticarcillin clavulanate|Ticarcillin-clavulanate]]'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Combination'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefazolin]]'''''<BR>''OR''<BR>▸ '''''[[Cefuroxime]]''''' <BR>''OR''<BR>▸ '''''[[Ceftriaxone]]''''' <BR>''OR''<BR>▸ '''''[[Cefotaxime]]''''' <BR>''OR''<BR>▸ '''''[[Ciprofloxacin]]''''' <BR>''OR''<BR>▸ '''''[[Levofloxacin]]'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=Left | PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Metronidazole]]'''''
|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''High risk or severe'''''
|-|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Single Agent'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Imipenem cilastatin|Imipenem-cilastatin]]'''''<BR>''OR''<BR>▸ '''''[[Meropenem]]'''''<BR>''OR''<BR> ▸ '''''[[Doripenem]]'''''<BR>''OR''<BR>▸ '''''[[piperacillin tazobactam|Piperacillin-tazobactam]]'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Combination'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefepime]]'''''<BR>''OR''<BR>▸ '''''[[Ceftazidime]]''''' <BR>''OR''<BR>▸ '''''[[Ciprofloxacin]]''''' <BR>''OR''<BR>▸'''''[[Levofloxacin]]'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=Left | PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Metronidazole]]'''''
|-
|-
|}
|}

Revision as of 19:05, 14 February 2014

Appendicitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Appendicitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Diagnostic Scoring

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Appendicitis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Appendicitis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendicitis

CDC on Appendicitis

Appendicitis in the news

Blogs on Appendicitis

Directions to Hospitals Treating Appendicitis

Risk calculators and risk factors for Appendicitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In combination with surgery, antibiotics are given intravenously to help kill bacteria and thus reduce the spread of infection in the abdomen and postoperative complications in the abdomen or wound.

Appendicitis Medical Therapy

Acute appendicitis is primary treated with surgery, either without rupture or with perforation and secondary peritonitis. Patients should be resuscitated with intravenous fluids, especially with septic shock.[1]

Pre-operative antibiotics used in acute appendicitis include cefuroxime and metronidazole. Equivocal cases may become more difficult to assess with antibiotic treatment and benefit from serial examinations.[2]

As blood cultures do not provide any additional clinical information for community-acquired intra-abdominal infection, they are not routinely recommended for such patients.[1]

Nonsurgical treatment may be used if:[3]

  • Surgery is not available
  • If a person is not well enough to undergo surgery
  • If the diagnosis is unclear

The duration of post-operative treatment with intravenous antibiotics ranges from 5 to 10 days, until fever resolves, white blood cell count normalizes, and bowel function returns.

Some research suggests that appendicitis can get better without surgery. Nonsurgical treatment includes antibiotics to treat infection and a liquid or soft diet until the infection subsides. A soft diet is low in fiber and easily breaks down in the gastrointestinal tract.[4][5]

Timing of Antibiotic Therapy

Once the patient is diagnosed with appendicitis, antibiotics should be started immediately.[1]

Initial Empiric Treatment Recommendations

The following antibiotic regimens are recommended as an empiric treatment by the Surgical Infection Society and the Infectious Diseases Society of America.[1]

Community-acquired infection in pediatric patients
Single Agent
Ertapenem
OR
Meropenem
OR
Imipenem-cilastatin
OR
Ticarcillin-clavulanate
OR
Piperacillin-tazobactam
Combination
Preferred Regimen
Ceftriaxone
OR
Cefotaxime
OR
Cefepime
OR
Ceftazidime
PLUS
Metronidazole
Alternative Regimen
Gentamicin
OR
Tobramycin
PLUS
Metronidazole
OR
Clindamycin


Community-acquired infection in adults
Mild-to-moderate severity
Single Agent
Cefoxitin
OR
Ertapenem
OR
moxifloxacin
OR
Tigecycline
OR
Ticarcillin-clavulanate
Combination
Cefazolin
OR
Cefuroxime
OR
Ceftriaxone
OR
Cefotaxime
OR
Ciprofloxacin
OR
Levofloxacin
PLUS
Metronidazole
High risk or severe
Single Agent
Imipenem-cilastatin
OR
Meropenem
OR
Doripenem
OR
Piperacillin-tazobactam
Combination
Cefepime
OR
Ceftazidime
OR
Ciprofloxacin
OR
Levofloxacin
PLUS
Metronidazole

References

  1. 1.0 1.1 1.2 1.3 Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ; et al. (2010). "Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America". Clin Infect Dis. 50 (2): 133–64. doi:10.1086/649554. PMID 20034345.
  2. Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 978-0-443-06839-3.
  3. Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 978-0-443-06839-3.
  4. Kirshenbaum M, Mishra V, Kuo D, Kaplan G (2003). "Resolving appendicitis: role of CT". Abdom Imaging. 28 (2): 276–9. doi:10.1007/s00261-002-0025-3. PMID 12592478.
  5. Cobben LP, de Van Otterloo AM, Puylaert JB (2000). "Spontaneously resolving appendicitis: frequency and natural history in 60 patients". Radiology. 215 (2): 349–52. doi:10.1148/radiology.215.2.r00ma08349. PMID 10796906.

Template:WH Template:WS